Printer Friendly
The Free Library
19,607,059 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Coolibar Secures Start Up Funding; Anti-Cancer Clothing Available Late May.


Business Editors & Health/Medical Writers

MINNEAPOLIS--(BUSINESS WIRE)--March 27, 2002

Coolibar LLC (Logical Link Control) See "LANs" under data link protocol.

LLC - Logical Link Control
 announced today it has closed an initial $500,000 round of private equity financing Equity Financing

The act of raising money for company activities by selling common or preferred stock to individual or institutional investors. In return for the money paid, shareholders receive ownership interests in the corporation.
. This funding, combined with bank and trade financing plus initial seed capital, will enable the Minneapolis-based sun-protective clothing company to enter the national market by late May.

"We have exceeded our own expectations by raising our first round of equity capital one month ahead of schedule," said John Barrow John Barrow may refer to one of several people:
  • John Barrow (historian)
  • Sir John Barrow, 1st Baronet, an English statesman
  • John D. Barrow (b. 1952), British theoretical physicist and author
  • John Barrow (U.S.
, founder and president of Coolibar. "The range of investors -- including prospective customers, dermatologists, pediatricians, pharmacists, direct marketing executives and investment bankers -- demonstrates knowledgeable people's awareness of the need for sun-protective products in the U.S. market and the strength of our business model."

Over the last 25 years melanoma rates have almost tripled in America. According to the National Cancer Institute, American males now have a 1 in 58 lifetime chance of getting melanoma while American females have a 1 in 82 chance of being diagnosed with melanoma.

Coolibar designs and markets high quality, certified sun protection products including clothing, hats, swimwear, sunscreen sunscreen /sun·screen/ (-skren) a substance applied to the skin to protect it from the effects of the sun's rays.

sun·screen
n.
, sunglasses and shade devices. Coolibar's clothing provides protection from the sun's harmful rays by an Ultraviolet Protection Factor (UPF UPF Universitat Pompeu Fabra (Barcelona, Spain)
UPF University Press of Florida
UPF Ultraviolet Protection Factor
UPF Universal Preservation Format
UPF Upcountry People's Front (Sri Lanka) 
) between 30 and 50, while regular summer clothing has a UPF rating of between 6 and 7. Sun protective clothing Sun protective clothing is clothing specifically designed for sun protection and is produced from a fabric rated for its level of ultraviolet (UV) protection. A novel weave structure and denier (related to thread count per inch) may produce sun protective properties.  also provides better protection than sunscreen because typically, people don't apply enough sunscreen and then don't reapply Re`ap`ply´   

v. t. & i. 1. To apply again.

reapply vivolver a presentarse, hacer or presentar una nueva solicitud

 it as often as they should.

Coolibar was founded in 2001 to bring Australia's world-leading approaches to skin cancer prevention to the American market. The company has extensively redesigned Australian sun-protective clothing styles to meet the tastes and needs of fashion- and health-conscious Americans. For more information about Coolibar, go to www.coolibar.com or call 800/926-6509.
COPYRIGHT 2002 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Mar 27, 2002
Words:293
Previous Article:REPEAT/BLUE Industries Inc. Acquires Patent License From EAUDEGAM S.A.
Next Article:Premium Network Inc.'s Audience Verified by NetScore at 88 Million Unique Monthly Visitors Worldwide.



Related Articles
Pummeling tumors with localized therapies.
IL-12 studies back on track.
Assay to reveal health role of compounds.
There goes the sun: when it comes to ultraviolet exposure, it pays to be pale. (Consumer News).
GPC BIOTECH GETS U.S. PATENT FOR ANTI-CANCER CELL INHIBITOR.
GPC BIOTECH/DEBIOPHARM SIGN MHC II ANTAGONISTS LICENSE PACT.
Enzyme stopper combats cancers.
Polyp stopper: controversial drug may prevent colon growths.
Engineering a cure: genetically modified cells fight cancer.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles